Skip to main content
Robert Soiffer, MD, Oncology, Boston, MA

RobertJSoifferMD

Oncology Boston, MA

Hematologic Oncology

Professor of Medicine, Dana-Farber Cancer Institute

Dr. Soiffer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Soiffer's full profile

Already have an account?

  • Office

    44 Binney St
    # Dana
    Boston, MA 02115
    Phone+1 617-632-4731
    Fax+1 617-632-5175

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1989
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1986
  • New York University School of Medicine
    New York University School of MedicineClass of 1983

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • MA State Medical License
    MA State Medical License 1986 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Boston Magazine Castle Connolly, 2009-2013
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Small-Molecule BCL6 Inhibitor Effectively Treats Mice with Non-Sclerodermatous Chronic Graft-Versus-Host Disease  
    Joseph H Antin, Bruce Blazar, Leo Luznik, John Koreth, Ivan Maillard, Robert J Soiffer, James E Bradner, Jonathan S Serody, Jerome Ritz, Blood

Abstracts/Posters

  • Distinct Evolutionary Patterns in Chronic Lymphocytic Leukemia (CLL) during Resistance to Graft-Versus-Leukemia (GvL)
    Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Feasibility and Impact of Embedded Geriatric Consultation for Frail Older Adults with Blood Cancer: A Randomized Controlled Trial
    Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...
    Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • BMT Peds and Adult 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Progression Risk-Based Classification of Asymptomatic Waldenström Macroglobulinemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Gut Bacteria Engineered to Act as Tumor GPS for Immunotherapies
    Gut Bacteria Engineered to Act as Tumor GPS for ImmunotherapiesOctober 4th, 2024
  • New Research Offers Hope for Safer and More Effective Blood Stem Cell Transplants
    New Research Offers Hope for Safer and More Effective Blood Stem Cell TransplantsSeptember 4th, 2024
  • Drug Companies Set Sights on New COVID Medicines to Boost Depleted Arsenal
    Drug Companies Set Sights on New COVID Medicines to Boost Depleted ArsenalDecember 27th, 2022
  • Join now to see all

Grant Support

  • Immune Modulation/Hematopoietic Cell TransplantationNational Institute Of Allergy And Infectious Diseases2005–2010
  • Induction Of Anti-Tumor Immunity After Allogeneic Hematopoietic Cell TransplantNational Institute Of Allergy And Infectious Diseases2007–2009
  • Induction Of Anti-Tumor Immunity After HC TransplantNational Institute Of Allergy And Infectious Diseases2005–2006
  • Administrative &Communications CoreNational Institute Of Allergy And Infectious Diseases2005
  • T Cell Infusions After Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2000–2002
  • Immunologic Manipulation Of Donor Marrow PRE And Post Allogeneic BMTNational Institute Of Allergy And Infectious Diseases1996–1998